VTRO (Vitro Biopharma) Other Financing: $-1.18 Mil (TTM As of Oct. 2022)


What is Vitro Biopharma Other Financing?

Vitro Biopharma VTRO Other Financing is $-1.18 Mil as of Oct. 2022. The stock has 6 warning signs investors should review.

Vitro Biopharma's Other Financing for the three months ended in Oct. 2022 was $-1.18 Mil.

Vitro Biopharma's Other Financing for the trailing twelve months (TTM) ended in Oct. 2022 was $-1.18 Mil.

Vitro Biopharma Other Financing Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma Other Financing Chart

Vitro Biopharma Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.14 0.00 0.00 -1.18

Vitro Biopharma Quarterly Data
Oct00 Oct01 Oct02 Oct03 Oct04 Oct05 Oct06 Oct07 Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.14 0.00 1.79 -1.18

Vitro Biopharma Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $-1.18 Mil mean?
Vitro Biopharma (VTRO) has a Other Financing of $-1.18 Mil as of Oct. 2022. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Vitro Biopharma and its competitors.
Is Vitro Biopharma's Other Financing too high?
Vitro Biopharma's current Other Financing is $-1.18 Mil.
How does Vitro Biopharma's Other Financing compare to ?
Vitro Biopharma's Other Financing of $-1.18 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Vitro Biopharma and its competitors. Vitro Biopharma's current Other Financing is $-1.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitro Biopharma stock overvalued right now?
Vitro Biopharma (VTRO) has a current Other Financing of $-1.18 Mil. The current Other Financing is $-1.18 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current Other Financing is $-1.18 Mil as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Comparable Companies
Address 4621 Technology Drive, Golden, CO, USA, 80403
Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.